![]() |
市場調查報告書
商品編碼
1559481
打鼾防止設備:市場洞察·競爭環境·市場預測 (~2030年)Anti-Snoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
防打鼾設備市場規模將從2023年的16.1億美元成長到2030年的25.8億美元,在2024年至2030年的預測期內複合年增長率為7.02%。
由於睡眠障礙和憂鬱症、慢性阻塞性肺病和肥胖等危險因子的盛行率不斷增加,以及強調睡眠重要性的睡眠意識活動和計劃的激增,預計從2024 年到2030 年,防打鼾設備市場將出現成長由於在預測期內技術先進的睡眠設備的推出預計會增加,預計睡眠量將顯著增長。
根據 DelveInsight 的分析,預計 2021 年七個主要國家診斷出的阻塞性睡眠呼吸中止症 (OSA) 病例總數為 24,165,544 例。根據世界衛生組織 (WHO) 2021 年報告,2019 年全球約有 2.8 億人患有憂鬱症。幾項研究報告稱,患有憂鬱症的人可能在晚上難以入睡和保持睡眠狀態,或者可能在白天過度嗜睡。
根據全球疾病負擔研究的數據,2019年全球報告的慢性阻塞性肺病病例數為2.123億。慢性阻塞性肺病會導致持續且進行性的呼吸道症狀,例如呼吸困難、咳嗽和產生痰。因此,慢性阻塞性肺病患者也會出現睡眠呼吸暫停,導致一種稱為 "重疊綜合症" 的疾病。
肥胖等嚴重疾病也會加劇各種睡眠障礙的症狀並破壞個人的睡眠品質。對於肥胖的人來說,脂肪會在上呼吸道中堆積,使上呼吸道變窄,並減少這些區域的肌肉活動,導致缺氧和呼吸中止發作,從而導致睡眠呼吸中止症等睡眠障礙。這些因素的相互作用預計將在預測期內提振市場。
本報告提供全球打鼾防止設備的市場調查,彙整市場概要,市場影響因素及市場機會分析,法律制度,市場規模的轉變·預測,各種區分·地區/各主要國家的詳細分析,競爭情形,主要企業簡介等資訊。
Anti Snoring Devices Market by Device Type (Mandibular Advancement Devices, Tongue Stabilizing Devices, Continuous Positive Airway Pressure (CPAP) Devices, and Others), Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of sleep apnea and its risk factors such as depression, COPD, obesity, surging number of sleep awareness campaigns and programs, among others across the globe.
The anti snoring devices market was valued at USD 1.61 billion in 2023, growing at a CAGR of 7.02% during the forecast period from 2024 to 2030 to reach USD 2.58 billion by 2030. The anti snoring devices market is poised for substantial growth, owing to the increasing prevalence of sleep disorders and risk factors such as depression, COPD, and obesity, among others, surge in the number of sleep awareness campaigns and programs highlighting the importance of sleep, the rising launch of technologically advanced sleep devices during the forecast period from 2024 to 2030.
Anti Snoring Devices Market Dynamics:
As per DelveInsight analysis, in 2021, the estimated total diagnosed cases of obstructive sleep apnea (OSA) in the 7MM region was 24,165,544. According to World Health Organization 2021, worldwide around 280 million people were suffering from depression in 2019. Several research studies have concluded that individuals going through depression may find it difficult to fall and stay asleep during the night or experience periods of excessive daytime sleepiness.
As per data from the Global Burden of Disease Study, there were 212.3 million prevalent cases of COPD reported in 2019 globally. COPD causes persistent and progressive respiratory symptoms, including difficulty in breathing, cough, and phlegm production. Thus, people with COPD will also have sleep apnea, the combination leading to a condition called "overlap syndrome".
Severe conditions such as obesity also aggravate the symptoms of various sleep disorders that may disrupt the sleep quality of an individual. In obese people, fat deposits in the upper respiratory tract narrow the airway; decreasing muscle activity in this region, leading to hypoxic and apneic episodes, ultimately resulting in sleep discrepancies such as sleep apnea. Thus, the interplay of all the above-mentioned factors is expected to boost the market for anti snoring devices during the forecasted period.
However, the various complications associated with anti snoring devices, the unreliable efficacy, and the lack of proven studies for the use of anti snoring devices, among others may act as restraining factors for the overall growth of the anti snoring devices during the forecast period.
Anti Snoring Devices Market Segment Analysis:
Anti Snoring Devices Market by Device Type (Mandibular Advancement Devices, Tongue Stabilizing Devices, Continuous Positive Airway Pressure (CPAP) Devices, and Others), Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the device type segment of the anti-snoring devices market, the Continuous Positive Airway Pressure (CPAP) Devices category is projected to hold a considerable market share in 2023. The various advantages associated with CPAP therapy and the various product development activities such as launches are expected to drive the market demand for this category during the forecast period.
CPAP ventilators deliver a constant pressure of air, both while inhaling and exhaling, due to which CPAP ventilators form one of the most common forms of treatment procedures for the management of mild obstructive sleep apnea. CPAP includes automatic PAP therapy (APAP) as well, which uses an automatically adjusting positive airway pressure machine to treat obstructive sleep apnea. APAP devices may also be referred to as auto-titrating CPAP or auto-CPAP machines.
Moreover, in February 2024, ResMed announced the launch of its AirFit F40 ultra-compact, full-face mask indicated for sleep apnea. The device offers the comfort of smaller masks without sacrificing performance, thus helping with sleep apnea therapy compliance for users of high-pressure continuous positive airway pressure (CPAP) treatment.
Thus, all the above-mentioned factors are expected to boost the market for the CPAP category, thereby escalating the overall market for anti snoring devices during the forecast period.
North America is expected to dominate the overall anti snoring devices market:
North America is expected to account for the highest proportion of the Anti Snoring Devices market in 2023, out of all regions North America is expected to dominate the overall Anti Snoring Devices market during the forecast period.
The major factors driving the market for anti snoring devices in North America are the rising prevalence of sleep-related issues among the population, the presence of key organizations for creating awareness, and product development activities, among other activities across the region during the forecast period. As per data by the Centers for Disease Control and Prevention 2022, around 17.8% of adults had trouble staying asleep owing to various reasons such as sleep apnea in the US in 2020.
Further, the American Sleep Apnea Association 2023 stated that nearly 84 million people which means one in three American adults do not get the required uninterrupted sleep due to snoring and breathing difficulties regularly.
The presence of organizations such as the National Sleep Foundation (NSF), independently creates Sleep Awareness Week each year as the flagship campaign for sleep health awareness and education in the US.
NSF recognizes evidence and consensus-based best practices for sleep health throughout Sleep Awareness Week, including professional advice and useful pointers to assist people in getting the necessary quantity and quality of sleep.
Thus, the interplay of all the aforementioned factors is likely to fuel the regional market growth and demand for anti snoring devices in North America during the forecasted period from 2024 to 2030.
Anti Snoring Devices Market Key Players:
Some of the key market players operating in the Anti Snoring Devices market include Koninklijke Philips NV, Apnea Sciences, ResMed, SomnoMed, GSK plc., Meditas, Evantis Inc., Rotech Healthcare, The Pure Sleep Company, Innovative Health Technologies, Tomed GmbH, Fisher and Paykel Healthcare Limited, Whole You Inc., AccuMED Corporation, Vyaire Medical, and others.
Recent Developmental Activities in the Anti Snoring Devices Market:
Key Takeaways from the Anti Snoring Devices Market Report Study:
Target audience who can be benefited from this Anti Snoring Devices Market Report Study:
Frequently Asked Questions for the Anti Snoring Devices Market:
Anti snoring devices are devices that help keep the nasal passages open and relieve snoring. Nasal snoring can be relieved with the use of nasal anti-snoring devices such as nasal strips, and nasal dilators, among others that keep the nostrils open during sleep.
The anti snoring devices market was valued at USD 1.61 billion in 2023, growing at a CAGR of 7.02% during the forecast period from 2024 to 2030 to reach USD 2.58 billion by 2030.
The anti snoring devices market is poised for substantial growth, owing to the increasing prevalence of sleep disorders and risk factors such as depression, COPD, and obesity, among others, the surge in the number of sleep awareness campaigns and programs highlighting the importance of sleep, the rising launch of technologically advanced sleep devices during the forecast period from 2024 to 2030.
Some of the key market players operating in the Anti Snoring Devices market include Koninklijke Philips NV, Apnea Sciences, ResMed, SomnoMed, GSK plc., Meditas, Evantis Inc., Rotech Healthcare, The Pure Sleep Company, Innovative Health Technologies, Tomed GmbH, Fisher and Paykel Healthcare Limited, Whole You Inc., AccuMED Corporation, Vyaire Medical, and others.
North America is expected to account for the highest proportion in the Anti Snoring Devices market in 2023, out of all regions. The major factors driving the market for anti snoring devices in North America are the rising prevalence of sleep-related issues among the population, the presence of key organizations for creating awareness, and product development activities, among other activities across the region during the forecast period.